期刊文献+

血清SCC-Ag、NSE、CA125联合检测对肺癌的诊断价值 被引量:16

Diagnostic value of combined detection of serum SCC-Ag、NSE and CA125 levels for hung cancer
下载PDF
导出
摘要 目的探讨血清肿瘤标志物SCC-Ag、NSE和CA125在肺癌诊断中的临床价值。方法分别测定82例肺癌患者、38例肺良性疾病患者、30例健康人血清中的SCC-Ag、NSE和CA125水平。结果肺癌患者组的三种肿瘤标志物水平均高于肺良性疾病患者组和正常对照组(P<0.05)。其中血清中SCC-Ag、NSE、CA125的敏感性分别为64.6%、43.9%、40.2%,三者联合检测的敏感性为86.6%。SCC-Ag在鳞癌的敏感性最高为75.0%;NSE在小细胞未分化癌敏感性最高为78.6%;CA125在腺癌的敏感性为76.9%。结论血清SCC-AG、NSE和CA125检测有助于临床对肺癌的诊断,并对组织分型有较高的参考价值。 Objective To appraise the clinical value of SCC-Ag, NSE and CA125 in the diagnosis of lung cancer. Methods Serum levels of SCC-AG,NSE,CA125 in 82 patients with lung cancer,38 patients with benige lung diseases and 30 normal controls were measured. Results The levels of SCC-Ag, NSE, CA125 in lung cancer group were significandy higher than those in benign lung diseases and normal control groups( P 〈 0. 05 ). Sensitivities of SCC-Ag, NSE and CA 125were 64. 6% ,43.9% , and 40. 2% , respectively. Sensitivity of combined detection of three kinds tumor markers was 86.6%. Of three markers,sensitivity of SCC-Ag was the highest(75.0% ) in patients with lung squamous cell carcinoma. Sensitivity of NSE was the highest(78.6% ) in patient with small cell undifferentiated car-cinoma of lung. And sensitivity of CA125 was the highest(76.9% ) in patients with lung adenoearcinoma. Conchusions The Serun levels of SCC-Ag, NSE and CA125 are helpful in diagnosis of lung cancer and Especially. It is Valuable to differentiating various histological type of lung cancer.
出处 《临床肺科杂志》 2009年第11期1455-1457,共3页 Journal of Clinical Pulmonary Medicine
关键词 肺癌 SCC—Ag NSE CA125 lung cancer SCC-Ag NSE CA125
  • 相关文献

参考文献4

二级参考文献18

  • 1谢朝辉,袁昕.小细胞肺癌患者血清NSE检测的临床意义[J].中华肿瘤防治杂志,2001,12(z1):238-239. 被引量:3
  • 2齐法莲,杨道理,安娟,罗南萍,王波涛.多项血清学指标在肺癌患者中的应用价值[J].临床肿瘤学杂志,1998,3(3):9-11. 被引量:3
  • 3Watanabe R, Takiguchi Y, Kuriyama T. Serum tumor markers for primary lung carcinoma. Nippon Rinsho, 2000,58(5) : 1070-- 1073.
  • 4Schneider J, Veleovsky H G, Morr H, et al. Comparison of the tumor markers M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer[J]. Antieaneer Res.2000,20: 5053--5058.
  • 5Polberg K,Stepulak A,Stryjecka-Zimmer M,Kupisz K,Zawislak J.Squamous cell carcinoma antigen levels in patients with laryngeal cancer.Pol Merkuriusz Lek,2005,19(111):375 -376.
  • 6Maeda Y,Segawa Y,Takigawa Net al.Clinical usefulness Of serum cytokeratin 19 fragment as a tumor marker for lung cancer.InternMed,1996,35(3):764 -778.
  • 7GiovanellaL,PiantanidaR,CerianiL,et al.Immunoassay of neuron specific enolase (NSE) and serum fragments of cytokeratinl9 (CYFRA21-1)as tumor markers in small cell lung cancer:clinical evaluation and biological hypotheses.Int J Biol Markers,1997,12:22 -34.
  • 8Molina R,Filella X,Auge JM,Bosch E,Torne A,Pahisa J,Lejarcegui JA,Rovirosa A,Mellado B,Ordi J,Biete A..CYFRA 21.1 in patients with cervical cancer:comparison with SCC and CEA.Anticancer Res,2005,25(3A):1765-1771.
  • 9Puthucode-Easwaran S,Naik R,Athavale R,Handley G,Lopes A,Godfrey K,Hatem M.Comparison of pre-treatment CYFRA 21-1 and SCC-Antigen assay in primary cervical carcinoma-a preliminary report.J Obstet Gynaecol,2005,25(5):486 -488.
  • 10陈书盘,耿沁.评价酶联免疫检测血清CYFRA21-1对非小细胞肺癌的诊断价值[J].肿瘤,1997,17(5):258-261. 被引量:9

共引文献112

同被引文献185

引证文献16

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部